Skip to content
healthcare.dev

Halobetasol Propionate

NDC 21922-108, Halobetasol Propionate, ointment, from Encube Ethicals, Inc..

Product NDC
21922-108
Status
Listed
Labeler
Encube Ethicals, Inc.
Dosage form
OINTMENT
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209978
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/21922-108 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HALOBETASOL PROPIONATE.5 mg/g

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

Package NDCNDC-11Package
21922-108-04219220108041 TUBE in 1 CARTON (21922-108-04) / 15 g in 1 TUBE
21922-108-14219220108141 TUBE in 1 CARTON (21922-108-14) / 50 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d4f03a79-3d5e-4a39-8ab0-8ebd3d804e39

Use it

Look up 21922-108 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/21922-108 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 21922-108. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.